Ennature Bio Pharma Secures BSE and NSE Listing Approvals Post-Demerger
India Glycols Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 4:46 am
Ennature Bio Pharma Secures BSE and NSE Listing Approvals Post-Demerger Ennature Bio Pharma Limited received listing and trading approvals from BSE and NSE on 2nd Nov'26 for 2,23,42,255 equity shares (face value Rs. 5 each), allotted pursuant to the Scheme of Arrangement involving India Glycols Limited and IGL Spirits Limited. Trading in the equity shares is scheduled to commence on 4th Nov'26 across both exchanges.
Original exchange filing (PDF)
More announcements from India Glycols Ltd
- Please find attached. 路 17 Nov 2026
- Please find atached. 路 13 Nov 2026
- India Glycols Limited has informed the Exchange about General Updates 路 13 Nov 2026
- Please find attached. 路 13 Nov 2026
- India Glycols Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Please refer to attachment. 路 13 Nov 2026
- Please find attached 路 18 Nov 2026
- Please find attached 路 18 Nov 2026
